作为早期痴呆症患者的合作伙伴,在日常生活中进行导航:一个全面的审查
Mille Vogelius Bøtchiær1, Hanne Kaae Kristensen2,3
1University of Southern Denmark, Odense, Denmark.
Scandinavian journal of caring sciences
|August 6, 2025
概括
年轻发病痴呆症 (YOD) 患者的配偶护理人员在多个支持领域中经历了重大未满足的需求. 量身定制的干预措施对于应对这些挑战和改善护理人员福祉至关重要.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
背景情况:
- 年轻发病痴呆症 (YOD) 患者的配偶护理人员往往缺乏足够的信息和准备.
- 照顾YOD带来了独特的挑战,影响了工作与生活的平衡和个人责任.
- 在现有的文献中,对YOD配偶护理人员的具体需求仍然在很大程度上未被探索.
研究的目的:
- 进行范围审查,以确定和绘制YOD患者配偶照顾者的生活经历.
- 确定照顾YOD患者的配偶照顾者的未满足需求.
主要方法:
- 在包括Embase,Scopus和PubMed在内的多个数据库中进行了系统的文献搜索.
- 专注于YOD患者的配偶护理人员的研究被选并根据预定义的纳入标准进行选择.
- 采用数据提取和主题分类来分析这种护理人员人群的经验和需求.
主要成果:
- 出现了五个主要主题:心理教育,社会,实践,情感/心理和导航支持需求.
- 护理人员报告了社会隔离,经济压力,角色冲突和情绪困扰.
- 在获得和协调医疗保健服务方面发现了重大挑战,强调了倡导的必要性.
结论:
- 患有YOD的人的配偶照顾者在各种支持层面上都有广泛的未满足需求.
- 当前的支持系统在个人,社会和系统层面上存在差距,使护理经验复杂化.
- 未来的干预措施必须提供可访问,全面和量身定制的支持服务,以应对这些护理人员面临的独特挑战.
更多相关视频
06:52Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
Published on: September 30, 2020
10.0K
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
3.9K
相关概念视频
Documentation in Long-Term and Home Healthcare Setting
1.6K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.6K
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Dementia
696
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
696
Alzheimer Disease l: Introduction
38
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
38
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
